Literature DB >> 24503987

Genome Sequences of Four Acinetobacter baumannii-A. calcoaceticus Complex Isolates from Combat-Related Infections Sustained in the Middle East.

Patrick Ketter1, M Neal Guentzel, James P Chambers, James Jorgensen, Clinton K Murray, Andrew P Cap, Jieh-Juen Yu, Mark Eppinger, Bernard P Arulanandam.   

Abstract

Acinetobacter baumannii is among the most prevalent bacterial causes of combat-related infections on the battlefield. Antibiotic resistance and a poor understanding of the protective host immune responses make treatment difficult. Here, we report the genome sequences of four clinical Acinetobacter baumannii-A. calcoaceticus complex isolates exhibiting significant differences in virulence in a mouse sepsis model.

Entities:  

Year:  2014        PMID: 24503987      PMCID: PMC3916481          DOI: 10.1128/genomeA.00026-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Acinetobacter baumannii accounts for >36% of combat-related infections resulting from injuries sustained by military service personnel in the Middle East, making it among the most prevalent bacterial pathogens encountered on the battlefield (1, 2). Ubiquitous in nature, A. baumannii resists desiccation, allowing the pathogen to survive in relatively arid environments most other bacteria cannot (3–5). This, in combination with the increased level of antibiotic resistance associated with A. baumannii and its ability to colonize various bodily sites, makes these infections difficult to control and treat (3, 6–11). The limited genomic plasticity and biochemical conservation among Acinetobacter species pose problems with regard to species identification in clinical settings, resulting in A. baumannii and Acinetobacter calcoaceticus often being reported as the A. baumannii-A. calcoaceticus complex (ABC) (10, 12). Genomic heterogeneity in A. baumannii has an established impact on patient outcome based on variations of the virulence and antibiotic resistance gene alleles present in each strain (13–16). To this end, we sequenced four clinical multidrug-resistant ABC strains, CI77, CI78, CI79, and CI86, from a collection obtained from respiratory (CI78 and CI79) or wound (CI77 and CI86) cultures from military personnel injured in either Iraq or Afghanistan (17). In a murine sepsis model, we observed significant differences in virulence in vivo between strains CI77 and CI79 correlating to sustained and elevated blood serum levels of an acute-phase small pattern recognition receptor known as PTX3; PTX3 possesses antimicrobial properties following challenge with strain CI79 (P. M. Ketter, M. N. Guentzel, B. Schaffer, M. Herzig, X. Wu, C. G. Fedyk, J. Yu, J. Jorgensen, J. P. Chambers, A. P. Cap, and B. P. Arulanandam, submitted for publication). Genomic DNA was subjected to Illumina sequencing using paired-end libraries with 300-bp inserts on the HiSeq 2000 platform. The draft genome was assembled with the Velvet assembler (18, 19), and the IGS Annotation Engine and Manatee were used for structural and functional genome annotation and visualization of the chromosomes and plasmid contigs (20). The observed genome sizes of the isolates range from 3.8 to 4.2 Mb, with an average G+C content of 38%. In silico comparison of the 16s rRNA genes allowed the complex and species attribution of CI77, CI79, and CI86 as being pathogenic A. baumannii strains, while CI78 is representative of A. calcoaceticus, is generally considered nonpathogenic, and is found to occasionally colonize but rarely cause infection in humans (10, 12). We determined the carriage of several reported A. baumannii virulence factors, such as LpxC, PglL, and AbaI (21–23), and found only limited genomic plasticity among the analyzed Middle Eastern ABC isolates. The availability of these sequences as a reference in RNAseq analysis will assist in future studies examining alterations in the ABC complex transcriptome and will help enhance our understanding of the underlying genetics and regulatory pathways leading to altered clinical disease manifestation in patients infected with emerging pathogens of ABC.

Nucleotide sequence accession numbers.

The genome sequences of the Acinetobacter clinical isolates CI77, CI78, CI79, and CI86 have been deposited in GenBank under accession no. AVOC00000000, AVOE00000000, AVOD00000000, and AVOB00000000, respectively.
  23 in total

Review 1.  The epidemiology and control of Acinetobacter baumannii in health care facilities.

Authors:  Pierre Edouard Fournier; Hervé Richet
Journal:  Clin Infect Dis       Date:  2006-01-26       Impact factor: 9.079

2.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

3.  Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.

Authors:  Joshua S Hawley; Clinton K Murray; Matthew E Griffith; M Leticia McElmeel; Letitia C Fulcher; Duane R Hospenthal; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

4.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.

Authors:  J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

5.  Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq.

Authors:  Duane R Hospenthal; Helen K Crouch; Judith F English; Fluryanne Leach; Jane Pool; Nicholas G Conger; Timothy J Whitman; Glenn W Wortmann; Janelle L Robertson; Clinton K Murray
Journal:  J Trauma       Date:  2011-07

6.  Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii.

Authors:  J G Koeleman; M W van der Bijl; J Stoof; C M Vandenbroucke-Grauls; P H Savelkoul
Journal:  Infect Control Hosp Epidemiol       Date:  2001-05       Impact factor: 3.254

7.  The emergence of resistant strains of Acinetobacter baumannii: clinical and infection control implications.

Authors:  M E Dy; J A Nord; V J LaBombardi; J W Kislak
Journal:  Infect Control Hosp Epidemiol       Date:  1999-08       Impact factor: 3.254

8.  Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.

Authors:  Chen Niu; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

9.  Mortality associated with Acinetobacter baumannii complex bacteremia among patients with war-related trauma.

Authors:  Grace Kang; Joshua D Hartzell; Robin Howard; Robert N Wood-Morris; Mark D Johnson; Susan Fraser; Amy Weintrob; Glenn Wortmann
Journal:  Infect Control Hosp Epidemiol       Date:  2010-01       Impact factor: 3.254

10.  Multidrug-resistant Acinetobacter baumannii.

Authors:  Aharon Abbo; Shiri Navon-Venezia; Orly Hammer-Muntz; Tami Krichali; Yardena Siegman-Igra; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

View more
  6 in total

1.  Thioredoxin-mediated alteration of protein content and cytotoxicity of Acinetobacter baumannii outer membrane vesicles.

Authors:  Swathi Shrihari; Holly C May; Jieh-Juen Yu; Sara B Papp; James P Chambers; M Neal Guentzel; Bernard P Arulanandam
Journal:  Exp Biol Med (Maywood)       Date:  2021-10-29

2.  Draft Genome Assembly of Acinetobacter baumannii ATCC 19606.

Authors:  Karen W Davenport; Hajnalka E Daligault; Timothy D Minogue; David C Bruce; Patrick S G Chain; Susan R Coyne; James G Jaissle; Galina I Koroleva; Jason T Ladner; Po-E Li; Gustavo F Palacios; Matthew B Scholz; Hazuki Teshima; Shannon L Johnson
Journal:  Genome Announc       Date:  2014-08-21

3.  CRISPR-cas subtype I-Fb in Acinetobacter baumannii: evolution and utilization for strain subtyping.

Authors:  Nabil Karah; Ørjan Samuelsen; Raffaele Zarrilli; Jason W Sahl; Sun Nyunt Wai; Bernt Eric Uhlin
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

4.  Thioredoxin-A is a virulence factor and mediator of the type IV pilus system in Acinetobacter baumannii.

Authors:  Holly C May; Jieh-Juen Yu; Hao Zhang; Yufeng Wang; Andrew P Cap; James P Chambers; M Neal Guentzel; Bernard P Arulanandam
Journal:  PLoS One       Date:  2019-07-02       Impact factor: 3.240

5.  Thioredoxin Modulates Cell Surface Hydrophobicity in Acinetobacter baumannii.

Authors:  Holly C May; Jieh-Juen Yu; Swathi Shrihari; Janakiram Seshu; Karl E Klose; Andrew P Cap; James P Chambers; M Neal Guentzel; Bernard P Arulanandam
Journal:  Front Microbiol       Date:  2019-12-11       Impact factor: 5.640

6.  Acinetobacter baumannii Gastrointestinal Colonization Is Facilitated by Secretory IgA Which Is Reductively Dissociated by Bacterial Thioredoxin A.

Authors:  Patrick M Ketter; Jieh-Juen Yu; M Neal Guentzel; Holly C May; Rishein Gupta; Mark Eppinger; Karl E Klose; J Seshu; James P Chambers; Andrew P Cap; Bernard P Arulanandam
Journal:  MBio       Date:  2018-07-10       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.